We are live on ! Find out more
SCNI

Scinai Immunotherapeutics
SCNI

17 hedge funds and large institutions have $560K invested in Scinai Immunotherapeutics in 2021 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

6% more funds holding

Funds holding: 16 → 17 (+1)

0% less ownership

Funds ownership: 0% → 0% (-0%)

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

37% less capital invested

Capital invested by funds: $891K → $560K (-$331K)

Holders
17
Holders Change
+1
Holders Change %
+6.25%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
3
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
+$57.2K
2
Citadel Advisors
Citadel Advisors
Florida
+$46.5K
3
TPWA
TRUE Private Wealth Advisors
Oregon
+$30.8K
4
HF
HRT Financial
New York
+$8.47K
5
UBS Group
UBS Group
Switzerland
+$2.82K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$259K
2
Millennium Management
Millennium Management
New York
-$33K
3
Morgan Stanley
Morgan Stanley
New York
-$15.7K
4
ASN
Advisory Services Network
Georgia
-$14K
5
State Street
State Street
Massachusetts
-$1.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
State Street
1
State Street
Massachusetts
$175K -$1.8K -7 -0.9%
Morgan Stanley
2
Morgan Stanley
New York
$100K -$15.7K -61 -12%
HF
3
HRT Financial
New York
$78K +$8.47K +33 +10%
TPWA
4
TRUE Private Wealth Advisors
Oregon
$59K +$30.8K +120 +80%
VF
5
Virtu Financial
New York
$49K +$57.2K +223 New
Citadel Advisors
6
Citadel Advisors
Florida
$40K +$46.5K +181 New
Geode Capital Management
7
Geode Capital Management
Massachusetts
$30K – – –
Credit Agricole
8
Credit Agricole
France
$9K – – –
Royal Bank of Canada
9
Royal Bank of Canada
Ontario, Canada
$6K – – –
UBS Group
10
UBS Group
Switzerland
$6K +$2.82K +11 +69%
NFG
11
Next Financial Group
Texas
$3K – – –
CAPTRUST Financial Advisors
12
CAPTRUST Financial Advisors
North Carolina
$2K -$513 -2 -17%
GRP
13
Global Retirement Partners
California
$1K – – –
Wells Fargo
14
Wells Fargo
California
$1K – – –
Bank of America
15
Bank of America
North Carolina
$1K +$1.03K +4 New
Renaissance Technologies
16
Renaissance Technologies
New York
– -$259K -901 Closed
Millennium Management
17
Millennium Management
New York
– -$33K -116 Closed
ASN
18
Advisory Services Network
Georgia
– -$14K -51 Closed
TRCT
19
Tower Research Capital (TRC)
New York
– +$257 +1 New

SCNI Hedge Fund Activity: Q3 2021 in Review

17 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Scinai Immunotherapeutics (SCNI) for Q3 2021, worth a combined $560K — down 37% from $891K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new SCNI positions and 3 closed out — a net gain of 1 holder — while 3 added to existing stakes and 3 trimmed.

The largest buyer was Virtu Financial, opening a new position worth an estimated $57.2K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $259K sold.

  • 17 institutional investors held Scinai Immunotherapeutics (SCNI) as of Q3 2021, up from 16 in Q2 2021.
  • Funds reported $560K of Scinai Immunotherapeutics stock for Q3 2021, down 37% quarter-over-quarter.
  • 4 funds opened new Scinai Immunotherapeutics positions in Q3 2021 and 3 closed out, a net change of +1 holder.
  • The largest Scinai Immunotherapeutics buyer in Q3 2021 was Virtu Financial, an estimated $57.2K added.
  • The largest Scinai Immunotherapeutics seller in Q3 2021 was Renaissance Technologies, an estimated $259K sold.

Based on aggregated 13F filings for Q3 2021.